Status:
UNKNOWN
Effects of Lidocaine Infusion on Quality of Recovery and Agitation After Functional Endoscopic Sinus Surgery
Lead Sponsor:
Alexandria University
Conditions:
Chronic Polypous Rhinosinusitis
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
The essential anesthesia requirements for FESS include airway management, considerations for facilitating surgical access, provision of a clear and still surgical field for precision surgery, assuring...
Detailed Description
Lidocaine is an amino amide-type short-acting local anesthetic (LA). It has a short half-life, and a favorable safety profile, and is therefore the LA of choice for continuous IV administration, it ha...
Eligibility Criteria
Inclusion
- Patients scheduled for elective functional endoscopic sinus surgery;
- ASA class I-II,
- aged (20-60 years).
Exclusion
- Body mass index \>35 kg/m2
- History of allergic reaction to local anesthetic agents especially lignocaine.
- History of preoperative use of opioids.
- Patients with history of uncontrolled hypertension, A-V conduction block.
- History of sleep apnea.
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 20 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04472689
Start Date
July 1 2020
End Date
October 20 2020
Last Update
August 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rehab Abd Elraof Abd Elaziz
Alexandria, Egypt, 000000